Life Science REIT plc announced the letting of 29,661 sq. ft. across the entirety of Building 6A at Oxford Technology Park to Oxford Ionics Limited .

Oxford Ionics is an existing occupier at OTP and the new lease is more than six times its existing footprint of 4,887 sq. ft. at Building 1. Oxford Ionics's proprietary Electronic Qubit Control technology provides the most stable and scalable method for delivering quantum computing technology.

Its pioneering performance enables the design of better catalysts used in processes such as drug discovery, experimentation in test tubes or real-time simulation on computers. Building 6A is an innovative, high-tech hybrid building which provides a contemporary office style frontage with flexible internal space allowing the office, R&D laboratory and production content of buildings to vary from 25% to 50% to suit a range occupier requirements. It is targeting a BREEAM Excellent certification.

Oxford Ionics will pay an annual rent of PS593,220, equating to PS20.0 psf for a ten-year term, with a break clause and rent review at the end of the fifth year. OTP was acquired by Life Science REIT in May 2022. It now comprises five completed buildings totaling 173,400 sq.

ft. and 333,200 sq. ft.

of development space. Existing occupiers at the park include The Native Antigen Company, a developer and manufacturer of antigens and antibodies, and Oxford Gene Technology, a provider of clinical research and diagnostic solutions.